Integrating expression-based drug respon
โ
Bonnie E. Gould Rothberg; Tennore M. Ramesh; Catherine E. Burgess
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 410 KB
๐ 2 views
In the third millennium, competitive advantage in drug development will derive from expertise in two areas: 1) the ability to prioritize and triage hits from a combinatorial chemistry/high-throughput screening experiment and pursue only those hits most likely to succeed through clinical development,